Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant thymin alpha-1 and its prepn

A technology of thymosin and pgex-4t-1, applied in the field of medical bioengineering, can solve the problems of high chemical synthesis cost and environmental pollution

Inactive Publication Date: 2004-11-24
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The present invention adopts genetic engineering technology to prepare recombinant thymosin α1 to overcome the disadvantages of high chemical synthesis cost and environmental pollution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant thymin alpha-1 and its prepn

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] Example 1: Construction of fusion expression vector pGEX-4T-1 / Tα1

[0008] 1. Reagents and materials

[0009] The vector plasmid pGEX-4T-1 was donated by Dr. Pan Xinghua, Department of Medical Genetics, Yale University, USA

[0010] Escherichia coli E.coli BL21(DE3)Ply S strain was purchased from Stratagene Company

[0011] Human Placenta Marathon-Roady TM -cDNA was purchased from Clontech Company

[0012] Restriction endonuclease and T4 DNA ligase were purchased from Shanghai Huamei Company

[0013] PCR primers were synthesized by Shanghai Jikang Biotechnology Co., Ltd.

[0014] Gel recovery kit was purchased from Shanghai Sangon Biotechnology Co., Ltd.

[0015] 2. Method

[0016] (1) Design and synthesis of oligonucleotide primers: designed according to GenBank (accession number: S38640)

[0017] Upstream primer 5′-GG GGATCC GACGCAGCCGTAGAC-3′

[0018] Downstream primer 5′-GG GAATTC TTATTTTCTGCCTCTTCCAC-3′

[0019] The upstream primer contains a BamHI rest...

Embodiment 2

[0024] Embodiment 2: Fermentation of Escherichia coli engineering bacteria DE3 / pGEX-4T-1 / Tα1

[0025] 1. Take a small amount of Escherichia coli engineering bacteria DE3 / pGEX-4T-1 / Tα1 in 20ml LB medium containing 100μg / ml ampicillin (peptone 10g / L, yeast powder 5g / L, NaCl 5g / L) and shake at 37°C Cultivate overnight as the primary seed solution.

[0026] 2. Get the primary seed solution, inoculate it with 4% inoculum in 200ml LB medium containing 100 μg / ml ampicillin, and cultivate it with shaking at 37° C. for 6 hours in a Erlenmeyer shaker flask as the secondary seed solution.

[0027] 3. According to the 4% inoculum size of the working volume of the fermenter, insert the secondary seed liquid into the semi-synthetic medium [(every liter contains: tryptone 5g, yeast extract 5g, glycerol 10g, KH 2 PO 4 2g,K 2 HPO 4 4g, Na 2 HPO 4 12H 2 O 7g, (NH 4 ) 2 SO 4 1.2g, NH 4 Cl 0.2g)] and trace element solution (every liter containing: MnSO 4 ·5H 2 O 0.001g, CoCl 2 ·6...

Embodiment 3

[0030] Example 3: Preparation and purification of Gly-Tα1 protein:

[0031] 1. Centrifuge the fermented bacteria liquid to collect the bacteria, and use phosphate buffer solution (PBS: NaCl 140mmol / L KCl2.7mmol / L Na 2 HPO 4 10mmol / L KH 2 PO 4 1.8mmol / L (pH7.3) was centrifuged and washed once, and then 10ml of PBS was added for each gram of wet weight of bacteria to suspend the bacteria to precipitate.

[0032] 2. Ultrasonically break the bacteria in an ice bath, centrifuge, take the supernatant and pass it through the Glutathione Sepharose 4B column, discard the passing peak, and use 50mmol / L Tris-HCl, 10mmol / L reduced glutathione (pH8.0) Elution is carried out, and the elution peak is collected to obtain GST-Tα1 fusion protein.

[0033] 3. Add GST-Tα1 fusion protein to PBS or 50mmol / L Tris-HCl, 2.5mmol / L CaCl 2 , 150mmol / L NaCl (pH8.0) dialysis, add thrombin at a rate of 50-500μg fusion protein per unit of thrombin digestion, react at 25-30°C for 2-16 hours, and genera...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The present invention relates to the field of medicinal bioengineering technology and is a recombinant thymin alpha-1, that is Gly-T alpha-1, and its preparation method. The gene engineering process to prepare Gly-T alpha-1 includes PCR to amplify gene segment with 5'-GGGGATCCGACGCAGCCGTAGAC-3' as upstream primer, 5'-GGGAATTCTTATTTTCTGCCTCTTCCAC-3' as downstream primer and human placenta CDNA as template, EcoRI / BamHI double enzyme incision for directional cloning of destination gene to pGEX-4T-1 to constitue fused expression vector pGEX-4T-1 / T alpha-1. The prepared engineering bacterium can express glutathion S-transferase- thymin alpha-1 fusion protein and affinity chromatography purified fusion protein, and thrombase incision releases Gly-T alpha-1, which is finally purified by the affinity chromatography and ion exchange chromatography.

Description

Technical field: [0001] The invention relates to the technical field of medical bioengineering, and relates to a recombinant thymosin α1 and a preparation method thereof. Background technique: [0002] Thymosin α1 (thymosin α1, referred to as Tα1) is a polypeptide composed of 28 amino acid residues, which has immune activity and is mostly used clinically to treat viral hepatitis. The amino acid sequence of native Tα1 is NH 2 -Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu -Ala-Glu-Asn-COOH, N-terminus is acetylated [Goldstein A L, Low TL, McAdoo M, McClure J, Thurman GB, Rossio J, Lai C Y, Chang D, Wang S S, Harvey C, Ramel A H, Meienhofer. J. Thymosin alpha 1: isolation and sequence analysis of an immunological active thymic peptide. Proc Natl Acad Sci USA, 1977, 74(2): 725-729]. At present, there is only one source of Tα1 monomer, which is fully synthesized by solid phase synthesis, which is costly and easy to cause e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/32A61P37/02C07K14/575C12N15/16
Inventor 郭葆玉苗红章杰袁鹏群道书艳邱磊张冉
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com